SCOPUS 정보 검색 플랫폼

Volumn 15, Issue 10, 2001, Pages 1650-1657

TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy

(3) Lincz, L F a Yeh, T X b Spencer, A b

a Newcastle Mater Misericordiae (Australia)

b ALFRED HOSPITAL (Australia)

Author keywords

Apoptosis; Multiple myeloma; TRAIL

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CYTOKINE RECEPTOR; FAS ANTIGEN; FAS LIGAND; LEUCINE ZIPPER PROTEIN; MESSENGER RNA; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER CELL CULTURE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG RESISTANCE; DRUG SENSITIVITY; ERADICATION THERAPY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INCUBATION TIME; LEUKEMIA CELL LINE; LYMPHOBLASTOID CELL LINE; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TUMOR CELL;

EID: 0034776231 PISSN: 08876924 EISSN: None Source Type: Journal
DOI: 10.1038/sj.leu.2402251 Document Type: Article

Times cited : (68)

References (32)

1
- 0032915294
- Survival in conventionally treated younger (<60 years) multiple myeloma patients: No improvement during two decades
- Nordic Myeloma Study Group (NMSG).
- (1999) Eur J Haematol , vol.62 , pp. 271-277
- Hjorth, M.¹ Holmberg, E.² Rodjer, S.³ Turesson, I.⁴ Westin, J.⁵ Wisloff, F.⁶

2
- 0024357763
- Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma
- (see comments)
- (1989) Lancet , vol.2 , pp. 882-885
- Samson, D.¹ Gaminara, E.² Newland, A.³ Van de Pette, J.⁴ Kearney, J.⁵ McCarthy, D.⁶ Joyner, M.⁷ Aston, L.⁸ Mitchell, T.⁹ Hamon, M.¹⁰ Barrett, A.J.¹¹ Evans, M.¹²

3
- 8944220233
- A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
- Inter-groupe Francais du Myelome (see comments).
- (1996) New Engl J Med , vol.335 , pp. 91-97
- Attal, M.¹ Harousseau, J.L.² Stoppa, A.M.³ Sotto, J.J.⁴ Fuzibet, J.G.⁵ Rossi, J.F.⁶ Casassus, P.⁷ Maisonneuve, H.⁸ Facon, T.⁹ Ifrah, N.¹⁰ Payen, C.¹¹ Bataille, R.¹²

4
- 0029166629
- Autologous stem cell transplantation in multiple myeloma: Results of the European Group for Bone Marrow Transplantation
- (1995) Stem Cells , vol.13 , pp. 140-146
- Bjorkstrand, B.¹ Ljungman, P.² Bird, J.M.³ Samson, D.⁴ Brandt, L.⁵ Alegre, A.⁶ Auzanneau, G.⁷ Blade, J.⁸ Brunet, S.⁹ Carlson, K.¹⁰

5
- 0030763774
- How TRAIL kills cancer cells, but not normal cells
- (news; comment)
- (1997) Science , vol.277 , pp. 768
- Gura, T.¹

6
- 0032929520
- Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
- (see comments)
- (1999) Nat Med , vol.5 , pp. 157-163
- Walczak, H.¹ Miller, R.E.² Ariail, K.³ Gliniak, B.⁴ Griffith, T.S.⁵ Kubin, M.⁶ Chin, W.⁷ Jones, J.⁸ Woodward, A.⁹ Le, T.¹⁰ Smith, C.¹¹ Smolak, P.¹² Goodwin, R.G.¹³ Rauch, C.T.¹⁴ Schuh, J.C.¹⁵ Lynch, D.H.¹⁶

7
- 0032713075
- Safety and antitumor activity of recombinant soluble Apo2 ligand
- (1999) J Clin Invest , vol.104 , pp. 155-162
- Ashkenazi, A.¹ Pai, R.C.² Fong, S.³ Leung, S.⁴ Lawrence, D.A.⁵ Marsters, S.A.⁶ Blackie, C.⁷ Chang, L.⁸ McMurtrey, A.E.⁹ Hebert, A.¹⁰ DeForge, L.¹¹ Koumenis, I.L.¹² Lewis, D.¹³ Harris, L.¹⁴ Bussiere, J.¹⁵ Koeppen, H.¹⁶ Shahrokh, Z.¹⁷ Schwall, R.H.¹⁸

8
- 0034022160
- Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
- (2000) Nat Med , vol.6 , pp. 564-567
- Jo, M.¹ Kim, T.² Seol, D.³ Esplen, J.E.⁴ Dorko, K.⁵ Billiar, T.R.⁶ Strom, S.C.⁷

9
- 0030996297
- The receptor for the cytotoxic ligand TRAIL
- (1997) Science , vol.276 , pp. 111-113
- Pan, G.¹ O'Rourke, K.² Chinnaiyan, A.M.³ Gentz, R.⁴ Ebner, R.⁵ Ni, J.⁶ Dixit, V.M.⁷

10
- 0030762815
- An antagonist decoy receptor and a death domain-containing receptor for TRAIL
- (see comments)
- (1997) Science , vol.277 , pp. 815-818
- Pan, G.¹ Ni, J.² Wei, Y.F.³ Yu, G.⁴ Gentz, R.⁵ Dixit, V.M.⁶

11
- 0030792712
- Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
- (see comments)
- (1997) Science , vol.277 , pp. 818-821
- Sheridan, J.P.¹ Marsters, S.A.² Pitti, R.M.³ Gurney, A.⁴ Skubatch, M.⁵ Baldwin, D.⁶ Ramakrishnan, L.⁷ Gray, C.L.⁸ Baker, K.⁹ Wood, W.I.¹⁰ Goddard, A.D.¹¹ Godowski, P.¹² Ashkenazi, A.¹³

12
- 0030880548
- TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
- (1997) EMBO J , vol.16 , pp. 5386-5397
- Walczak, H.¹ Degli-Esposti, M.A.² Johnson, R.S.³ Smolak, P.J.⁴ Waugh, J.Y.⁵ Boiani, N.⁶ Timour, M.S.⁷ Gerhart, M.J.⁸ Schooley, K.A.⁹ Smith, C.A.¹⁰ Goodwin, R.G.¹¹ Rauch, C.T.¹²

13
- 0030770614
- Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL
- (1997) J Biol Chem , vol.272 , pp. 25417-25420
- MacFarlane, M.¹ Ahmad, M.² Srinivasula, S.M.³ Fernandes-Alnemri, T.⁴ Cohen, G.M.⁵ Alnemri, E.S.⁶

14
- 0031239984
- TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL
- (1997) Curr Biol , vol.7 , pp. 693-696
- Screaton, G.R.¹ Mongkolsapaya, J.² Xu, X.N.³ Cowper, A.E.⁴ McMichael, A.J.⁵ Bell, J.I.⁶

15
- 0030869432
- Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
- (1997) J Exp Med , vol.186 , pp. 1165-1170
- Degli-Esposti, M.A.¹ Smolak, P.J.² Walczak, H.³ Waugh, J.⁴ Huang, C.P.⁵ DuBose, R.F.⁶ Goodwin, R.G.⁷ Smith, C.A.⁸

16
- 0031627483
- Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): A new receptor protecting lymphocytes from the death ligand TRAIL
- (1998) J Immunol , vol.160 , pp. 3-6
- Mongkolsapaya, J.¹ Cowper, A.E.² Xu, X.N.³ Morris, G.⁴ McMichael, A.J.⁵ Bell, J.I.⁶ Screaton, G.R.⁷

17
- 0031414749
- The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
- (1997) Immunity , vol.7 , pp. 813-820
- Degli-Esposti, M.A.¹ Dougall, W.C.² Smolak, P.J.³ Waugh, J.Y.⁴ Smith, C.A.⁵ Goodwin, R.G.⁶

18
- 13144265771
- A novel receptor for Apo2L/TRAIL contains a truncated death domain
- (1997) Curr Biol , vol.7 , pp. 1003-1006
- Marsters, S.A.¹ Sheridan, J.P.² Pitti, R.M.³ Huang, A.⁴ Skubatch, M.⁵ Baldwin, D.⁶ Yuan, J.⁷ Gurney, A.⁸ Goddard, A.D.⁹ Godowski, P.¹⁰ Ashkenazi, A.¹¹

19
- 7344233085
- Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
- (1998) J Biol Chem , vol.273 , pp. 14363-14367
- Emery, J.G.¹ McDonnell, P.² Burke, M.B.³ Deen, K.C.⁴ Lyn, S.⁵ Silverman, C.⁶ Dul, E.⁷ Appelbaum, E.R.⁸ Eichman, C.⁹ DiPrinzio, R.¹⁰ Dodds, R.A.¹¹ James, I.E.¹² Rosenberg, M.¹³ Lee, J.C.¹⁴ Young, P.R.¹⁵

20
- 0032530612
- Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
- (1998) J Immunol , vol.161 , pp. 2833-2840
- Griffith, T.S.¹ Chin, W.A.² Jackson, G.C.³ Lynch, D.H.⁴ Kubin, M.Z.⁵

21
- 9844225051
- Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies
- (1997) Br J Haematol , vol.99 , pp. 618-624
- Snell, V.¹ Clodi, K.² Zhao, S.³ Goodwin, R.⁴ Thomas, E.K.⁵ Morris, S.W.⁶ Kadin, M.E.⁷ Cabanillas, F.⁸ Andreeff, M.⁹ Younes, A.¹⁰

22
- 0001560011
- Recombinant human TNF-related apoptosis inducing ligand (hu TRAIL) induces apoptosis of human multiple myeloma (MM) cells
- (1998) Blood , vol.10
- Treon, S.P.¹ Chauhan, D.² Raje, N.³ Teoh, G.⁴ Webb, I.⁵ Anderson, K.C.⁶

23
- 0003052641
- Freshly isolated myeloma cells show variable levels of apoptosis induced by recombinant human TNF-related apoptosis inducing ligand (TRAIL)
- Hobart
- (1999) 1st Annual Scientific Meeting of the Haematology Society of Australia and New Zealand. , pp. 175
- Lincz, L.F.¹ Spencer, A.²

24
- 0032717188
- TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells
- (1999) Leukemia , vol.13 , pp. 1817-1824
- Gazitt, Y.¹

25
- 0001329989
- Culture and biochemical analysis of cells
- Cold Spring Harbor Laboratory Press: New York
- (1998) Cells, A Laboratory Manual , vol.1
- Spector, D.L.¹ Goldman, R.D.² Leinwand, L.A.³

26
- 0029738550
- BCR-ABL positive lymphoblastoid cells display limited proliferative capacity under in vitro culture conditions
- (1996) Br J Haematol , vol.94 , pp. 654-658
- Spencer, A.¹ Xiu-Hua, Y.² Chase, A.³ Goldman, J.M.⁴ Melo, J.V.⁵

27
- 0031005576
- Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
- (1997) Cell , vol.89 , pp. 309-319
- Simonet, W.S.¹ Lacey, D.L.² Dunstan, C.R.³ Kelley, M.⁴ Chang, M.S.⁵ Luthy, R.⁶ Nguyen, H.Q.⁷ Wooden, S.⁸ Bennett, L.⁹ Boone, T.¹⁰ Shimamoto, G.¹¹ DeRose, M.¹² Elliott, R.¹³ Colombero, A.¹⁴ Tan, H.L.¹⁵ Trail, G.¹⁶ Sullivan, J.¹⁷ Davy, E.¹⁸ Bucay, N.¹⁹ Renshaw-Gegg, L.²⁰ Hughes, T.²¹ more..

28
- 0033104741
- Functional analysis of TRAIL receptors using monoclonal antibodies
- (1999) J Immunol , vol.162 , pp. 2597-2605
- Griffith, T.S.¹ Rauch, C.T.² Smolak, P.J.³ Waugh, J.Y.⁴ Boiani, N.⁵ Lynch, D.H.⁶ Smith, C.A.⁷ Goodwin, R.G.⁸ Kubin, M.Z.⁹

29
- 0032865522
- False human hematopoietic cell lines: Cross-contaminations and misinterpretations
- (1999) Leukemia , vol.13 , pp. 1601-1607
- Drexler, H.G.D.¹ Dirks, W.G.² MacLeod, R.A.F.³

30
- 0033083990
- Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
- (1999) Cancer Res , vol.59 , pp. 734-741
- Keane, M.M.¹ Ettenberg, S.A.² Nau, M.M.³ Russell, E.K.⁴ Lipkowitz, S.⁵

31
- 4243813430
- TRAIL receptor expression and activity of TRAIL in primary B cell acute lymphoblastic leukemia (ALL) cells
- (1999) Blood , vol.94
- Clodi, K.W.¹ Wimmer, D.² Li, Y.³ Goodwin, R.⁴ Jaeget, U.⁵ Mann, G.⁶ Gadner, H.⁷ Younes, A.⁸

32
- 0012689130
- Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: A population based study
- (2000) Blood , vol.95 , pp. 7-11
- Lenhoff, S.¹ Hjorth, M.² Holmberg, E.³ Turesson, I.⁴ Westin, J.⁵ Nielsen, J.L.⁶ Wisloff, F.⁷ Brinch, L.⁸ Carlson, K.⁹ Carlsson, M.¹⁰ Dahl, I.M.¹¹ Gimsing, P.¹² Hippe, E.¹³ Johnsen, H.¹⁴ Lamvik, J.¹⁵ Lofvenberg, E.¹⁶ Nesthus, I.¹⁷ Rodjer, S.¹⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.